Unknown PHASE2 INTERVENTIONAL 2-arm NCT01186783

Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine (MODIfY)

Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by the Funny Channel Current (If) Inhibitor Ivabradine

Sponsor: KKS Netzwerk

Conditions Multiple Organ Dysfunction Syndrome

Interventions ivabradine

Updated 6 times since 2017 Last updated: Sep 7, 2010 Started: May 31, 2010 Primary completion: Nov 30, 2011 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Multiple Organ Dysfunction Syndrome, this trial is ongoing. The trial is conducted by KKS Netzwerk and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KKS Netzwerk
Martin-Luther-Universität Halle-Wittenberg
Servier

Data source: Martin-Luther-Universität Halle-Wittenberg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halle, Germany